Rotate your device

Please rotate your device to landscape mode
for the best experience.

Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Tofastar Tablet

Prescription Icon
Prescription Required

Marketer

Alembic Pharmaceuticals Ltd

Salt Composition

Tofacitinib (5mg)

Overview Tofastar Tablet

Rheumacin tablets are indicated for managing moderate to severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. This medication alleviates joint pain, tenderness, and swelling by suppressing inflammation, and it also helps retard the progression of bone and joint deterioration. Rheumacin may be administered alone or in conjunction with other therapies. The tablets can be ingested with or without food, ideally at the same time daily. Dosage is individualized based on your health status and concurrent medications; always adhere to your physician's instructions. Discontinue use only under your doctor's guidance, as abrupt cessation may exacerbate your condition. Commonly reported side effects include upper respiratory infections, headaches, diarrhea, and nasopharyngitis. Less frequent, but potentially serious, adverse events such as blood clots and gastrointestinal perforations necessitate immediate medical attention. Discuss any concerns regarding side effects with your doctor promptly. Pre-treatment blood work may be required, and initiation of therapy is contraindicated in the presence of infection. Inform your physician of any history of tuberculosis, herpes zoster, hepatic or renal impairment, hepatitis B or C, or pulmonary or venous thromboembolism before commencing treatment. Rheumacin can increase susceptibility to infections or worsen existing ones; minimize contact with individuals suffering from contagious illnesses (e.g., chickenpox, measles, influenza). This medication is unsuitable for individuals under 18 years of age and should not be used during pregnancy or breastfeeding unless deemed medically necessary by your physician. Regular monitoring by your doctor may be necessary.

Primary Ingredients of Tofastar Tablet

No information provided. Please provide the text you wish me to rephrase.

Uses of Tofastar Tablet

Managing rheumatoid, psoriatic, and ankylosing spondylitis, plus ulcerative colitis.

Major Benefits of Tofastar Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Tofastar Tablets can be consumed with or without food, though consistent timing is recommended.

Common Side effects of Tofastar Tablet:

  • Upper respiratory tract infection
  • Headache
  • Diarrhea
  • Nasopharyngitis (inflammation of the throat and nasal passages)

How to use Tofastar Tablet:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Tofastar Tablets can be consumed with or without food, though consistent timing is recommended.

How Tofastar Tablet works:

Janus kinase inhibition is the mechanism of action for Tofastar Tablet. By suppressing Janus kinase enzyme activity, it reduces immune system responsiveness and inflammation characteristic of conditions like rheumatoid arthritis and ulcerative colitis.

SAFETY ADVICE

AlcoholAlcoholSAFE

There are no known adverse interactions between Tofastar Tablet and alcohol consumption.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Tofastar tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Tofastar Tablets while breastfeeding is potentially hazardous. Studies in humans indicate a possibility of the medication transferring to breast milk, posing a risk to the infant.

DrivingDrivingSAFE

Driving ability is typically unaffected by Tofastar Tablet.

KidneyKidneyCAUTION

Patients with severe kidney impairment should exercise caution when using Tofastar Tablets. Dosage modification may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with severe hepatic impairment should exercise caution when using Tofastar tablets, potentially requiring dosage modification. Physician consultation is advised.

What if you forget to take Tofastar Tablet :

Should you forget a Tofastar Tablet dose, take it promptly. If, however, your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Tofastar Tablet

LabelValue
Chemical Category Pyrrolopyrimidine Analog
Developing Habits No.
Treatment Category Pain Relievers
Behavioral Class JAK inhibitors

FAQs on Tofastar Tablet

Before starting Tofastar Tablet, tell your doctor about any liver problems. Tofastar Tablet may raise liver enzymes in some individuals, so your liver function should be assessed beforehand. While it can be used in patients with mild to moderate liver impairment, it's contraindicated in those with severe impairment.
Taking Tofastar tablets may raise your risk of certain cancers, such as lymphoma and skin cancer, due to its effects on the immune system. Tell your doctor if you have or have ever had cancer.
Tofastar tablets treat moderate to severe rheumatoid arthritis, a joint inflammatory disease. It's prescribed when prior treatments proved ineffective or unsuitable, or early on if initial medications fail. Tofastar may be used alone or in combination with other drugs, like methotrexate.
You may begin to feel improvement from Tofastar Tablet within 2 to 8 weeks, with full effects typically seen after 3 to 6 months.
Before and during Tofastar Tablet treatment, blood tests may be necessary to monitor for anemia, neutropenia, lymphopenia, high cholesterol, and elevated liver enzymes, and to assess the drug's effects. Furthermore, your doctor might recommend a tuberculosis test beforehand, as Tofastar Tablet could exacerbate an existing infection.
Tofastar Tablet modifies the immune system, potentially lowering resistance to infection and increasing the risk of serious infections, such as tuberculosis, or life-threatening disseminated fungal, bacterial, or viral infections. Hospital treatment is recommended for such infections.
Taking Tofastar Tablet and tocilizumab together is not recommended. Since Tofastar Tablet weakens the immune system, combining it with another immunosuppressant like tocilizumab significantly raises the risk of infection and potential complications.
Tofastar Tablet
164
MRP 190
13% off